Dorsal hand vein responses to the α1-adrenoceptor agonist phenylephrine do not predict responses to the α2-adrenoceptor agonist dexmedetomidine
Authors:
- Jussi P. PostiJussi P. Posti
- Laura ValveLVLaura Valve
- Saku RuohonenSRSaku Ruohonen
- Juha AkkilaJAJuha Akkila
- Mika ScheininMSMika Scheinin
- Amir SnapirASAmir Snapir
- 1 February 2011
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 653 (1-3) , 70-74
Abstract
No abstract availableKeywords
Funding Information
- Clinical Drug Research Graduate School
- Finnish Heart Foundation
- Sigrid Juselius Foundation.
This publication has 23 references indexed in Scilit:
- Desensitization of vascular response in vivo: contribution of genetic variation in the α2B-adrenergic receptor subtypeJournal Of Hypertension, 2010
- Inositol trisphosphate and calcium signalling mechanismsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009
- Ethnic and Genetic Determinants of Cardiovascular Response to the Selective α 2 -Adrenoceptor Agonist DexmedetomidineHypertension, 2008
- Subtypes of functional α1- and α2-adrenoceptorsEuropean Journal of Pharmacology, 1998
- Familial studies of heritability of α1-adrenergic receptor responsiveness in superficial veins*Clinical Pharmacology & Therapeutics, 1997
- α2A-Adrenergic Receptor Stimulated Calcium Release Is Transduced by Gi-Associated Gβγ-Mediated Activation of Phospholipase CBiochemistry, 1997
- Clinical pharmacology, physiology and pathophysiology of superficial veins‐2.British Journal of Clinical Pharmacology, 1994
- In vivo studies on alpha-adrenergic receptor subtypes in human veinsNaunyn-Schmiedeberg's Archives of Pharmacology, 1991
- Genetic aspects of variability in superficial vein responsiveness to norepinephrineClinical Pharmacology & Therapeutics, 1991
- Receptors linked to inhibition of adenylate cyclase: additional signaling mechanismsThe FASEB Journal, 1988